enVVeno Medical Corp
envveno.comenVVeno Medical Corp (NASDAQ: NVNO) is a medical device company focused on developing a product candidate for commercialization, pending regulatory approval. The company has no disclosed revenue as of the fiscal year ended December 31, 2025, operating as a pre-commercial stage enterprise dependent on external financing. The 10-K filed March 26, 2026 notes the company has no sales infrastructure and limited marketing capability, and has raised capital through equity offerings including an at-the-market facility established with Ladenburg Thalmann & Co. Inc. in October 2025. The filing discloses reliance on a single facility whose loss could materially disrupt operations. No product approvals, commercial sales, or revenue figures are disclosed in the filing excerpts provided.
Products & Services
The filing references a product candidate subject to regulatory approval. No approved or commercially available products are identified in the filing excerpts.
Revenue Model
No revenue disclosed in the filing excerpts for FY2025. The company has raised capital through equity issuances and warrant transactions. An at-the-market offering agreement with Ladenburg Thalmann & Co. Inc. was entered into as of October 30, 2025.
Customers & Markets
No customers or commercial end markets are disclosed in the filing excerpts. The company is subject to federal healthcare regulations including the physician sunshine requirements under the PPACA, indicating an intended end market in healthcare.
Geographic Exposure
Incorporated and operating in the United States, subject to U.S. federal and state healthcare regulations. No international operations disclosed in the filing excerpts.
Financial Snapshot
Loading...
